The immunopathogenesis of autoimmune insulin-dependent diabetes in NOD mice entails defects in the development of macrophages (M$s) from hematopoietic precursors. The present study analyzes the cellular and molecular basis underlying our previous finding that the MO growth factor colony-stimulating factor 1 (CSF-1) promotes a reduced level of promonocyte proliferation and MO development from NOD bone marrow. CSF-1 stimulation of NOD marrow induced Mos to differentiate to the point that they secreted levels of tumor necrosis factor a equivalent to that of controls. However, CSF-1 failed to prime NOD M$s to completely differentiate in response to y-interferon, as shown by their decreased lipopolysaccharide-stimulated interleukin 1 secretion. These defects, in turn, were associated with an inability of CSF-1 to up-regulate c-fms (CSF-1 receptor) and Ifgr (y-interferon receptor) expression. Even though the combination of CSF-1 and y-interferon up-regulated c-fins and Ifgr transcript levels in NOD M#s to levels induced in control M$s by CSF-1 alone, the protein kinase C activities coupled to these receptors remained 4-fold lower in NOD M#s than in Mos derived from the marrow of diabetes-resistant NON and SWR control mice. Despite expressing the diabetogenic H-2g7 haplotype, Mos derived from cytokine-stimulated marrow of the NON.H-2g7 congenic stock were functionally more mature than similarly derived Ms%s from NOD mice. Whereas diabetes resistance was abrogated in 67% of irradiated (NOD x NON)F1 females reconstituted with NOD marrow, no recipients became diabetic after reconstitution with a 1:1 mixture of marrow from NOD and the congenic stock. Thus, failure to develop functionally mature monocytes may be of pathogenic significance in NOD mice.
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NOD is an inbred mouse strain characterized by a high incidence of T-cell-mediated autoimmune insulin-dependent diabetes (1) . Genetic outcross of NOD with the closely related but diabetes-resistant NON inbred strain has shown that diabetogenesis results from complex polygenic interactions between the rare H-2g7 major histocompatibility complex (MHC) haplotype (Kd, I-AM7, I-Enuil, Db) of NOD and non-MHC-linked susceptibility modifiers (2) . These diabetogenic interactions are initiated at the hematopoietic stem-cell level since diabetes resistance in (NOD x NON)F1 hybrids is abrogated by lethal irradiation and reconstitution with NOD bone marrow but not NON/Lt or F1 bone marrow (3, 4) . Several lines of evidence indicate that H-297-expressing antigen-presenting cells (APCs), such as macrophages (M0s) derived from NOD stem cells, fail to mediate the clonal deletion of f-cell autoreactive T cells and/or to activate immunoregulatory T cells. These include the finding that marrow-derived APCs, but not thymic epithelial cells, expressing the diabetes-resistant H-2nbl haplotype (Kb, I-Anbl,
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I-Ek, Db) of NON blocked the development of diabetogenic T cells from NOD bone marrow (4) . In addition, the inability of NOD APCs to activate immunoregulatory T cells in a syngeneic mixed-lymphocyte reaction was also found to be associated with homozygous expression of H-2g7 (5) .
Interactions between the H-2g7 haplotype and non-MHClinked background genes also underlie the MO developmental anomalies characteristic of NOD mice. NOD bone marrow cells proliferate poorly in response to several myeloid growth factors (6, 7) . The myeloid growth factor, colony-stimulating factor 1 (CSF-1) generates fewer phenotypically mature (Mac-3+) M6s from NOD marrow than from diabetesresistant strains (6) . This is consistent with the finding that peritoneal Mos from NOD mice are poor interleukin 1 (IL-1) secretors (5, 8) , since M0s reportedly do not acquire the ability to secrete IL-1,8 until the later stages of differentiation (9) . Further evidence for dysregulated monocyte function in NOD mice is reflected by the aberrant responses of cells in this lineage to y-interferon (IFN-y) stimulation. As expected, IFN-y, which induces MO differentiation and activation, inhibited CSF-1-stimulated proliferation of bone marrow cells from diabetes-resistant strains (6) . In contrast, IFN-y aberrantly increased CSF-1-stimulated proliferation of NOD bone marrow cells and increased the number of Mac-3+ progeny generated to levels equivalent to that produced from the marrow of control strains stimulated with CSF-1 alone (6). In addition, as a result of defects in background-specific trans-regulatory factors, IFN-y also aberrantly downregulated H-2g7 MHC class I expression in NOD peritoneal Mos (6) . Collectively, these results indicate that non-MHClinked genes either independently or through interaction with the diabetogenic H-2g7 haplotype contribute to impairments in monocyte differentiation and function in NOD mice. Antigens that are processed and presented in an ineffi'cient fashion can continue to stimulate T-cell proliferative responses in the periphery but are unable to induce tolerance (10, 11) . Similarly, activation-driven T-cell death requires quantitatively more antigenic stimulation than is required to trigger T-cell proliferation (12) . In addition, the stimulation of immunoregulatory T cells requires a more highly activated APC than is required to trigger effector T cells (13 (6) ]. After 4 days in culture, the growth factor-containing medium was replaced with either fresh medium alone or with medium containing lipopolysaccharide (LPS) at 10 ,jg/ml. After an additional 24-h incubation, the culture supernatants were harvested and assayed for IL-1 content in a C3H/HeJ thymocyte comitogenic assay as described (5) . Data are presented as units of IL-1 (mean + SEM) compared to a recombinant murine IL-la standard (Hoffman-La Roche). TNF-a content of the culture supernatants was assessed as described (15) in a WEHI 164 growth inhibition assay using recombinant murine TNF-a (Genzyme) as a standard.
Analysis of CSF-1 Receptor and IFN-y Receptor mRNA Levels. Total cellular RNA was extracted as described (16) from marrow cells cultured for the indicated periods of time in medium alone or with CSF-1 in the presence and absence of IFN-y. Northern blot analysis was performed as described (17) using the SM3 cDNA to detect c-fms transcripts encoding the CSF-1 receptor (18) and the MUIFN-yR cDNA to detect Ifgr transcripts encoding the IFN-y receptor (19) . The blots were also hybridized with a chicken f-actin cDNA probe (kindly supplied by Hendrick Bedigian, The Jackson Laboratory) to verify that equal. quantities of RNA were present in all samples.
Assay of Protein Kinase C (PKC) Activity Induced by CSF-1. Triplicate cultures of 105 bone marrow cells were seeded into flat-bottom 96-well microtiter plates in 0.2 ml of medium containing CSF-1 at 500 units/ml with and without IFN--y at 10 units/ml. At the indicated times, cellular PKC activity was assessed as described (20) . Briefly, the medium was removed and the cells were permeabilized with digitonin (10 Ag/ml) in a reaction buffer also containing 100 uM [y-32P]ATP (Amersham, PB.170) and a 9-aa (VRKRTLRRL) synthetic substrate (Sigma, V-2131; 100 ,uM) corresponding to the major PKC phosphorylation site of the epidermal growth factor receptor (21) . The cells were incubated for 15 min at 37°C, the reaction was terminated by addition of 25% (wt/vol) trichloroacetic acid, and 45 ,ul of reaction supernatant was spotted onto Whatman P81 filters. The filters were sequentially washed with 75 mM phosphoric acid and 75 mM sodium phosphate (pH 7.5), and then radioactivity was measured in a 8 scintillation counter (LKB) to assess PKC-driven phos- Fig. 1 compares LPS-stimulated IL-1 secretion of Mis derived from NOD marrow cultured in CSF-1 with and without IFN-y to that of similarly derived Mis from diabetesresistant control strains. Our previous study (6) documented that fewer phenotypically mature (Mac-3+) M9s are generated from CSF-1-stimulated NOD marrow than from CSF-1-stimulated marrow of the same diabetes-resistant control strains utilized in the present study (NON, SWR, NOD.H2nbl, and NON.H-2e7). Despite this difference in degree of phenotypic maturation, the levels of LPS-stimulated IL-1 secretion (7-12 units/ml) were equivalent in CSF- 1-elicited MOs from all of these strains (Fig. 1) . Similarly, the level of LPS-stimulated TNF-a secretion from NOD Mos derived in CSF-1 alone (42.0 ± 2.5 units/ml) was equivalent to that of similarly derived Mos from SWR/Bm controls (40.0 ± 1.9 units/ml). We have demonstrated (6) (Fig. 2) . IFN-y inhibits CSF-1-stimulated proliferation of NON and SWR marrow cells (6) , and as shown in Fig. 1 , primes Mos to become functionally more competent. In contrast, IFN-y aberrantly increases CSF-1-stimulated proliferation of NOD marrow cells (6) , and the Mois generated remain functionally immature (Fig. 1) . The differential effect of IFN-y on proliferation and activation of CSF-1-stimulated marrow from diabetes-susceptible and -resistant strains correlated with the levels of c-fms expression. As shown in Fig. 2 marrow cultured in CSF-1 alone. However, the addition of IFN-'y greatly decreased c-fms transcript levels in CSF-1-stimulated NON marrow and did not affect c-fms transcript levels in CSF-1-stimulated SWR marrow (Fig. 2) . /3actin transcript levels shown in Fig. 2 indicate that equivalent amounts of RNA were present in each sample.
CSF-1 stimulation normally primes Mos to be activated by
IFN-y by up-regulating expression of IFN-y receptor (Ifgr) locus on mouse chromosome 10 (25, 26). We therefore analyzed whether the aberrant IFN-y responses of CSF-1 elicited Mis from NOD mice was associated with decreased Ifgr expression. As expected, high levels of Ifgr transcripts were detected in marrow cells of diabetes-resistant NON and SWR mice cultured in CSF-1 alone. Ifgr transcript levels were much lower in NON and SWR marrow cells cultured in a combination of CSF-1 and IFN-y than in marrow cells from these strains cultured in CSF-1 alone (Fig. 2) . In contrast, Ifgr expression was not up-regulated in CSF-l-elicited Mos from NOD mice. However, Ifgr transcript levels in NOD marrow cells cultured in a combination of CSF-1 and IFN-y were aberrantly increased to levels equivalent to that of NON and SWR marrow cultured in CSF-1 alone (Fig. 2) Mos from diabetes-resistant NON and SWR control mice.
As shown in Fig. 3 , the levels of PKC activity were indistinguishable in NOD, NON, and SWR bone marrow cells cultured for 1 day in CSF-1 alone. However, by culture day 2, PKC activity had increased by -4-fold in CSF-1-stimulated bone marrow cells from diabetes-resistant NON and SWR control mice. In contrast, PKC activity only increased slightly in NOD bone marrow cells cultured for 2 days in CSF-1 (Fig. 3) . By culture day 4, CSF-1-stimulated PKC activity in NON and SWR bone marrow cells had returned to levels equivalent to that of NOD. Similar results were observed when bone marrow cells from these three strains were cultured in a combination of CSF-1 and IFN-y. The only difference noted was that even on culture day 1, PKC activity was significantly higher in Mos derived from NON and SWR bone marrow than in similarly derived M9s from NOD bone marrow (Fig. 3) . Thus, even though the combination of CSF-1 and IFN-y up-regulated c-fms and Ifgr transcript levels in NOD Mos to levels induced in control Mos by CSF-1 alone (Fig. 2) , the ability of these receptors to induce PKC activity remained low in NOD Mos. This reduced ability to activate PKC-coupled second messenger pathways, in turn, could account for the inability of this combination of cytokines to induce the differentiation of functionally mature Mos from NOD bone marrow.
Diabetogenic Significance of Impaired APC Development. As assessed by more normal IL-1 secretory responsiveness (Fig. 1 syngeneic mixed-lymphocyte reaction, and IL-1 administration in vivo prevents diabetes (5, 8) . Accordingly, we hypothesized that despite expressing the diabetogenic H-2g7 MHC haplotype, the more functionally mature M0s generated from NON.H-2g7 congenic marrow might be capable of blocking the development of diabetogenic T cells from NOD marrow. (NOD x NON)F1 females were lethally irradiated and reconstituted at 4 weeks of age with either a 1:1 mixture of NOD and NON.H-2g7 bone marrow cells or with NOD bone marrow cells alone. As expected from previous studies (3, 4) , the diabetes-resistance characteristic of unmanipulated F1 females was abrogated by reconstitution with NOD bone marrow alone, since four of six recipients developed diabetes by 40 weeks of age (Table 1) . However, none (zero of six) of the irradiated F1 hybrids reconstituted with a 1:1 mixture of NOD and NON.H-2g7 bone marrow cells became . Exposure to IFN-y also induces expression of an "occult" MHC class I-like molecule in both Mis and pancreatic 13 cells from NOD mice (35) . The initiation of 13-cell destruction requires both CD4+ and CD8+ T cells (22) . It is possible that these unusual IFN-y responses associated with abnormal PKC activation may impair the ability of APCs from NOD mice to stimulate autoreactive MHC class I-restricted CD8+ T cells to an activation state high enough to induce their destruction. These autoreactive T cells may then be efficiently targeted to pancreatic A cells expressing high levels of MHC class I restriction elements. T-cell mediated autoimmune diabetes in NOD mice results from complex interactions between multiple MHC and non-MHC-linked susceptibility modifiers (2) . The findings that APCs expressing a diabetes-resistant MHC haplotype can block the development of diabetogenic T cells from NOD bone marrow (4) and that immunostimulatory treatments up-regulating APC function also block disease (5, 8, 36) indicate that many of these complex polygenic interactions occur at the level of hematopoietically derived APCs. In general, a higher threshold of T-cell activation is required to induce tolerance than is required to trigger T-cell effector responses (10, 12) . Thus, genetic defects compromising the ability of APCs to process and/or present antigens efficiently or, alternatively, to provide costimulatory signals may impair the ability of these cells to induce tolerance without fully abrogating their ability to activate effector T-cell function. Indeed, the finding that diabetes is blocked either by intrathymic engraftment of syngeneic p cells into young prediabetic NOD mice (37) or by introduction of purified APCs from pancreatic lymph nodes (38) supports the concept that high concentrations of p-cell autoantigens within the thymus may compensate for the inability of APCs from NOD mice to present these antigens in a manner quantitatively sufficient to induce tolerance. This possibility is strongly supported by our demonstration in a competitive bone marrow chimera system that APCs that express the diabetogenic H-2g7 MHC haplotype but are functionally more mature than NOD APCs can block the development or peripheral activation of diabetogenic T cells. These results provide further evidence that the aberrant immunophenotypes exhibited by NOD APCs are the logical starting point for dissecting the complex interactions between MHC-and non-MHC-linked genes that control diabetogenesis.
